BACKGROUND There is debate over whether the recent increases seen in prostate cancer
are due to lead‐time bias from screening, or identification of clinically insignificant lesions …

The clinical and economic burden of prostate cancer in Canada is substantial, and is rising.
Studies indicate that 1 in 7 men will develop prostate cancer during their lifetime, and …

Objectives. The use of prostate-specific antigen (PSA) to screen for prostate cancer remains
controversial. Although it is still too early to measure directly the effects of PSA screening on …

Purpose: We examined the temporal trends in prostate cancer incidence and mortality rates
in the Seattle-Puget Sound region. Materials and Methods: Prostate cancer incidence and …

Interpretation of cancer incidence and mortality rates in a defined population requires an
understanding of multiple complex and interacting factors. These factors include the …

The international patterns and trends in prostate cancer incidence, survival, prevalence and
mortality were examined. Age‐standardized incidence and death rates among men in a …

PURPOSE: We assess the influence of prostate specific antigen screening on trends in
mortality rates in patients with prostate cancer. MATERIALS AND METHODS: The incidence …

Background Previous studies reported that prostate cancer incidence rates in the United
States declined for local-stage disease and increased for regional-and distant-stage disease …

BACKGROUND In the 1980s, prostate specific antigen (PSA) came into wide use as a
prostate carcinoma screening and detection method in the United States. Following the …

INTRODUCTION men, little is known about the causes of prostate cancer. Incidence rates
increase more sharply with age for prostate cancer than for any other cancer type. Prostate …